Amgen Inc (AMGN)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$270.00

Buy

$271.04

arrow-down$-4.31 (-1.57%)

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Prices updated at 13 May 2025, 13:12 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up1.61%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Mr. Robert A. Bradway
CEO
Mr. Robert A. Bradway
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
28,000
Head office
One Amgen Center Drive
Thousand Oaks
United States
91320-1799
mobile
+1 805 447-1000
letter
investor.relations@amgen.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Amy E. Miles
Independent Director
0.14m--0.36m-
Mr. Charles M. Holley, Jr
Independent Director
---0.39m-
Ms. Ellen J. Kullman
Independent Director
0.15m--0.38m-
Mr. Robert A. Eckert
Lead Independent Director
0.21m--0.45m-
Mr. Robert A. Bradway
Chairman of the Board, President and Chief Executive Officer
1.87m--24.43m-
Professor Dr. Tyler E. Jacks, PhD
Independent Director
0.14m--0.36m-
Mr. Jonathan P. Graham
Executive Vice President, General Counsel and Secretary
-----
Mr. Greg C. Garland
Independent Director
0.16m--0.40m-
Mr. Murdo Gordon
Executive Vice President, Global Commercial Operations
1.20m--8.47m-
Dr. James E. Bradner, M.D.
Executive Vice President, Research and Development
1.21m1.02m-14.91m-
Mr. Esteban Santos
Executive Vice President, Operations
-----
Dr. Wanda M. Austin
Independent Director
0.14m--0.37m-
Dr. Brian J. Druker, M.D.
Independent Director
0.14m--0.37m-
Dr. David M. Reese, M.D.
Executive Vice President and Chief Technology Officer
1.27m--8.13m-
Mr. Peter H. Griffith
Executive Vice President and Chief Financial Officer
1.13m--7.81m-
Ms. Nancy A. Grygiel
Senior Vice President and Chief Compliance Officer
-----
Dr. S. Omar Ishrak
Independent Director
---0.38m-
Ms. Rachna Khosla
Senior Vice President, Business Development
-----
Mr. Derek Miller
Senior Vice President, Human Resources
-----
Mr. Michael V. Drake
Independent Director
---0.38m-
Mr. Matthew C. Busch
Vice President, Finance and Chief Accounting Officer
-----
Ms. Mary E. Klotman
Independent Director
0.08m--0.30m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc52,870,4530.29781486580.28196730 Apr 20259.83
BlackRock Inc45,646,1480.24074-599823-1.29702830 Apr 20258.49
Capital Research and Management Company35,502,60923.3108212137158-30 Apr 20256.60
State Street Corp29,434,4140.302661173960.40043630 Apr 20255.47
Capital Group21,087,88213.747817319619-30 Apr 20253.92

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
05 Dec 2024-Mr. Jonathan P. Graham--28,903--
02 Dec 2024-Mr. Robert A. Bradway--393,855--
02 Dec 2024-Mr. Robert A. Bradway--90,000--
02 Dec 2024-Mr. Robert A. Bradway--573,855--
05 Nov 2024-Ms. Rachna Khosla316.9167,1858,383--
05 Nov 2024-Mr. Matthew C. Busch316.9159,8964,770--
04 Nov 2024-Mr. Charles M. Holley, Jr--10,114--
04 Nov 2024-Mr. Michael V. Drake--3,552--
09 Aug 2024-Mr. Charles M. Holley, Jr--9,777--
09 Aug 2024-Mr. Michael V. Drake--3,307--
31 Jul 2024-Ms. Nancy A. Grygiel333.28521,5838,771--
31 May 2024-Ms. Amy E. Miles--3,927--
31 May 2024-Mr. Charles M. Holley, Jr--9,574--
31 May 2024-Ms. Ellen J. Kullman--12,300--
31 May 2024-Mr. Robert A. Eckert--23,715--
31 May 2024-Professor Dr. Tyler E. Jacks, PhD--16,005--
31 May 2024-Mr. Greg C. Garland--12,374--
31 May 2024-Dr. Wanda M. Austin--6,544--
31 May 2024-Dr. Brian J. Druker, M.D.--6,472--
31 May 2024-Mr. Michael V. Drake--3,175--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.